Table 1. Examples of novel disease relationships.
| Disease 1 | Disease 2 | Pathway |
| Drug induced dyskinesia | Amyotrophic lateral sclerosis | FOSBPATHWAY |
| Inborn errors lipid metabolism | Crohn disease | Carnitine transport |
| Leukemia | Ehlers danlos syndrome | Role of PBX in fibroblasts signaling pathways |
| Acute erythroblastic leukemia | Hepatic porphyrias | AHSPPATHWAY |
| Tuberous sclerosis | Neural tube defects | Neural tube closure |
| Precancerous conditions | Listeria infections | Immune response MIF in innate immunity response |
| Crohn disease | Neural tube defects | Cofactor transport |
| Hyperhomocysteinemia | Von willebrand disease | BLOOD CLOTTING CASCADE |
| Pulmonary hypertension | Precancerous conditions | Development Endothelin-1/EDNRA signaling |
| Asthma | Ataxia telangiectasia | Regulation of DNA recombination |
| Atherosclerosis | Contact dermatitis | LDL metabolism during development of fatty streak lesion |
| Wolff parkinson white syndrome | Inborn errors metabolism | Regulation of fatty acid metabolic process |
| Respiratory syncytial virus infections | Adenoma | Transcription Role of AP-1 in regulation of cellular metabolism |
| Pulmonary hypertension | Endometrial neoplasms | Development Endothelin-1/EDNRA signaling |
| Colitis | Inborn errors metabolism | Response to glucocorticoid stimulus |
| Respiratory syncytial virus infections | Ataxia telangiectasia | Regulation of DNA recombination |
| Syndactyly | Hair diseases | Odontogenesis of dentine-containing tooth |
| Pulmonary eosinophilia | Ataxia telangiectasia | Regulation of DNA recombination |
| Glomerulonephritis | Pneumocystis pneumonia | Regulation of phagocytosis |
| Hereditary neoplastic syndromes | Autoimmune diseases | Negative regulation of mononuclear cell proliferation |
Column 3 indicates the pathway which has the greatest overall association strength with both diseases.